61 related articles for article (PubMed ID: 6315230)
1. Iv administration of a water-insoluble antimitotic compound entrapped in liposomes. Preliminary report on infusion of large volumes of liposomes to man.
Coune A; Sculier JP; Frühling J; Stryckmans P; Brassinne C; Ghanem G; Laduron C; Atassi G; Ruysschaert JM; Hildebrand J
Cancer Treat Rep; 1983 Nov; 67(11):1031-3. PubMed ID: 6315230
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of a water-insoluble compound entrapped in liposomes on L1210 leukemia in mice.
Brassinne C; Atassi G; Frühling J; Penasse W; Coune A; Hildebrand J; Ruysschaert JM; Laduron C
J Natl Cancer Inst; 1983 Jun; 70(6):1081-6. PubMed ID: 6574278
[TBL] [Abstract][Full Text] [Related]
3. Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetic data.
Sculier JP; Coune A; Brassinne C; Laduron C; Atassi G; Ruysschaert JM; Frühling J
J Clin Oncol; 1986 May; 4(5):789-97. PubMed ID: 3701394
[TBL] [Abstract][Full Text] [Related]
4. Distribution in man of 111In-labelled liposomes containing a water-insoluble antimitotic agent.
Frühling J; Coune A; Ghanem G; Sculier JP; Verbist A; Brassinne C; Laduron C; Hildebrand J
Nucl Med Commun; 1984 Apr; 5(4):205-8. PubMed ID: 6531147
[No Abstract] [Full Text] [Related]
5. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
6. Nocodazole entrapped into liposomes: no more effect on human CFU-C than free nocodazole.
Loos M; Delforge A; Mattelaer M; Laduron C; Brassinne C; Hildebrand J; Stryckmans P
Anticancer Res; 1981; 1(6):393-6. PubMed ID: 7344613
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor in patients with refractory solid tumors.
Beutel G; Glen H; Schöffski P; Chick J; Gill S; Cassidy J; Twelves C
Clin Cancer Res; 2005 Aug; 11(15):5487-95. PubMed ID: 16061865
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel via 1-hour infusion: clinical experience.
Greco FA; Hainsworth JD
Semin Oncol; 1996 Dec; 23(6 Suppl 16):91-3. PubMed ID: 9007131
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
Schaefer PL; Marks RS; Mahoney MR; Sloan JA; Bauman MD; Tazelaar HD; Kugler JW; Mailliard JA; Ebbert LP; Wiesenfeld M
Am J Clin Oncol; 2003 Jun; 26(3):236-40. PubMed ID: 12796591
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of high-dose etoposide phosphate in man.
Fields SZ; Budman DR; Young RR; Kreis W; Ingram R; Schulman P; Cherny RC; Wright J; Behr J; Snow C; Schacter LP
Bone Marrow Transplant; 1996 Nov; 18(5):851-6. PubMed ID: 8932836
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive iv hyperalimentation.
Jordan WM; Valdivieso M; Frankmann C; Gillespie M; Issell BF; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(3-4):197-205. PubMed ID: 6786737
[No Abstract] [Full Text] [Related]
16. [Liposomes as drug vehicles in the treatment of neoplasms].
Jamrozik-Kruk Z; Zmudziński J; Laskawiec G
Pol Tyg Lek; 1987 Apr; 42(15):427-30. PubMed ID: 3615270
[No Abstract] [Full Text] [Related]
17. Liposomes and cancer therapy.
Gregoriadis G; Florence AT
Cancer Cells; 1991 Apr; 3(4):144-6. PubMed ID: 1883687
[No Abstract] [Full Text] [Related]
18. Preliminary development and evaluation of a parenteral emulsion formulation of penclomedine (NSC-338720; 3,5-dichloro-2,4-dimethoxy-6-trichloromethylpyridine): a novel, practically water insoluble cytotoxic agent.
Prankerd RJ; Frank SG; Stella VJ
J Parenter Sci Technol; 1988; 42(3):76-81. PubMed ID: 3216265
[No Abstract] [Full Text] [Related]
19. Studies on the use of antimitotic drugs entrapped within liposomes and of their action on a human glioma cell line.
Firth G; Oliver AS; McKeran RO
J Neurol Sci; 1984 Feb; 63(2):153-65. PubMed ID: 6200574
[TBL] [Abstract][Full Text] [Related]
20. Trimetrexate: overall clinical results.
Bertino JR
Semin Oncol; 1988 Apr; 15(2 Suppl 2):50-1. PubMed ID: 2966986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
